Sensient Technologies director acquires 279 deferred shares

Q: How much deferred stock did Joseph Carleone acquire in SXT?

Director Joseph Carleone acquired 279 shares of deferred stock on September 30, 2026. His reported deferred-stock position following the acquisition was 24,517 shares.

Q: How many SXT common shares did Joseph Carleone hold?

Joseph Carleone’s separate direct common-stock holding was 23,789 shares, including restricted stock held under Sensient Technologies Corp.’s 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

The deferred stock converts to common stock one-for-one, with common shares issued when the director’s service ends.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Sensient Technologies Corp. (SXT) reported that director Joseph Carleone acquired 279 shares of deferred stock on September 30, 2026, through deferral of director fees under the Directors’ Deferred Compensation Plan. His reported deferred-stock position following the acquisition was 24,517 shares. Deferred stock converts to common stock one-for-one, and common shares will be issued when his service as a director ends. A separate direct common-stock holding was 23,789 shares, including restricted stock and shares held in a dividend reinvestment plan.

Insider Trade Summary

Grant/Award: 279.414 shares

Grant/Award 2 txns

Insider Carleone Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock ^{F2, F3, F4}	279.414	$0.00	$0.00
holding	Common Stock ^F1	--	--	--

Holdings After Transaction: Deferred Stock — 24,516.786 contracts (Direct); Common Stock — 23,789.02 shares (Direct)

Footnotes (4)

F1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F2. Deferred stock converts to common stock on a one-for-one basis.
F3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
F4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

Key Figures

Deferred stock acquired: 279 shares Deferred stock following transaction: 24,517 shares Common stock holding: 23,789 shares +1 more

4 metrics

Deferred stock acquired 279 shares Director-fee deferral on September 30, 2026

Deferred stock following transaction 24,517 shares Joseph Carleone’s reported position

Common stock holding 23,789 shares Joseph Carleone’s separate direct holding

Conversion ratio 1 common share per deferred stock share Deferred stock converts to common stock

Key Terms

Deferred stock, Directors’ Deferred Compensation Plan, restricted stock, dividend reinvestment plan

4 terms

Deferred stock financial

"Deferred stock converts to common stock on a one-for-one basis."

Directors’ Deferred Compensation Plan financial

"Deferral of director fees under Issuer's Directors' Deferred Compensation Plan."

restricted stock financial

"Includes shares of restricted stock held under Issuer's 2017 Stock Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

dividend reinvestment plan financial

"shares held in a dividend reinvestment plan."

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much deferred stock did Joseph Carleone acquire in SXT?

Director Joseph Carleone acquired 279 shares of deferred stock on September 30, 2026. His reported deferred-stock position following the acquisition was 24,517 shares.

How many SXT common shares did Joseph Carleone hold?

Joseph Carleone’s separate direct common-stock holding was 23,789 shares, including restricted stock held under Sensient Technologies Corp.’s 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/01/2026 - 05:19 PM Accepted by SEC EDGAR 10/01/2026 - 05:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carleone Joseph

(Last)

(First)

(Middle)

777 EAST WISCONSIN AVENUE

(Street)

MILWAUKEE

WISCONSIN

53202

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								23,789.02⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock	⁽²⁾	09/30/2026		A⁽³⁾		279.414		⁽⁴⁾	⁽⁴⁾	Common Stock	279.414	$0	24,516.786	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Deferred stock converts to common stock on a one-for-one basis.

3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR